The Directorate of Health
Marburg virus disease in Rwanda
10th October 2024
Since late September, Rwanda has reported 58 cases of Marburg virus, resulting in 13 deaths. This is the first time Marburg virus has been detected in Rwanda, though outbreaks have occurred in other African countries, such as Angola, the Democratic Republic of Congo, Kenya, South Africa, and Uganda.
Marburg virus, like Ebola, belongs to the family Filoviridae and causes viral hemorrhagic fever, which is often fatal. There is currently no vaccine or specific treatment for the Marburg virus, and the disease has a high mortality rate. Rwandan health authorities have implemented a range of infection prevention measures in response.
Marburg virus is not highly contagious and is not transmitted via respiratory droplets. Instead, it spreads through direct contact with blood and other body fluids of infected people. For travelers from Europe to Rwanda, the risk of infection is low. However, individuals working in healthcare settings in Rwanda face a higher risk if proper infection prevention and precaution is not adhered to including the proper use of personal protective equipment.
Travelers planning to visit Rwanda should stay informed about the current situation and follow the guidance provided by Rwandan health authorities. Those returning from Rwanda who develop symptoms—such as flu-like symptoms, high fever, headache, muscle pain, or gastrointestinal issues—are advised to seek medical attention promptly.
For further details, please see the European Centre for Disease Prevention and Control (ECDC) recommendations:
The Chief Epidemiologist